Kingfa Science & Technology (India) Ltd has submitted its quarterly monitoring report, confirming the utilization of funds from its ₹500 crore preferential issue. As of March 31, 2026, the company reported that ₹155.78 crore has been deployed, with ₹344.22 crore remaining. The report also confirmed nil deviation from the stated objectives of the issue, a key piece of information for investors.
During the fourth quarter of fiscal year 2026, Kingfa India deployed ₹40.63 crore. The funds were primarily allocated to general corporate purposes and plant machinery. Specific figures as of March 31, 2026, show ₹60.29 crore utilized for plant and machinery, and ₹29.51 crore allocated for general corporate purposes.
The confirmation of nil deviation signals that the company is adhering to its planned use of funds and regulatory requirements, which can help maintain investor confidence. Kingfa India had announced the preferential issue to support its growth initiatives, including capital expenditure and general corporate needs. A monitoring agency has been overseeing the fund utilization since September 2025, with a target for completing the issue's objectives set for June 2027.
Looking ahead, investor attention will likely focus on the deployment pace of the remaining ₹344.22 crore. Key areas to watch include progress on factory construction, R&D buildings, and land acquisition, as well as the full utilization of funds for general corporate purposes and plant machinery, all by the 2027 deadline. Subsequent monitoring reports will provide further insights into the company's fund deployment strategy.
